Chargement en cours...
Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
OBJECTIVES: Teicoplanin, a glycopeptide, is regarded as among the drug choices for methicillin-resistant Staphylococcus aureus (MRSA) infections. Few studies have evaluated the relationship between teicoplanin minimal inhibitory concentrations (MICs) and outcomes among patients with serious MRSA inf...
Enregistré dans:
| Publié dans: | Infect Drug Resist |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101025/ https://ncbi.nlm.nih.gov/pubmed/30147349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S171236 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|